Meeder Asset Management Inc T2 Biosystems, Inc. Transaction History

Meeder Asset Management Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Oct 17, 2019	SELL	$0.58 - $3.01 $490 - $2,543	-845 Closed	0 $0
Q2 2019 Aug 05, 2019	BUY	$1.47 - $3.16 $1,242 - $2,670	845 New	845 $1,000
Q1 2019 Apr 16, 2019	SELL	$2.56 - $4.48 $865 - $1,514	-338 Closed	0 $0
Q4 2018 Jan 17, 2019	BUY	$2.98 - $6.86 $175 - $404	59 Added 21.15%	338 $1,000
Q3 2018 Nov 02, 2018	BUY	$5.36 - $7.83 $1,264 - $1,847	236 Added 548.84%	279 $0
Q2 2018 Jul 24, 2018	BUY	$5.97 - $9.58 $256 - $411	43 New	43 $0

Ticker TTOO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 7,050,850
Market Cap $15.9M
Description
T2 Biosystems, Inc., an in vitro diagnostics company, develops diagnostic products and product candidates in the United States and internationally. Its technology enables detection of pathogens, biomarkers, and other abnormalities in various unpurified patient sample types, including whole blood, plasma, serum, saliva, sputum, cerebral spinal fl...

Get notified when there are updates to the investment portfolio of Meeder Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Meeder Asset Management Inc with notifications on news.